These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
579 related articles for article (PubMed ID: 33182499)
1. Molecular Mechanisms of "Antiphospholipid Antibodies" and Their Paradoxical Role in the Pathogenesis of "Seronegative APS". Misasi R; Longo A; Recalchi S; Caissutti D; Riitano G; Manganelli V; Garofalo T; Sorice M; Capozzi A Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182499 [TBL] [Abstract][Full Text] [Related]
2. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements. Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654 [TBL] [Abstract][Full Text] [Related]
3. The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study. da Rosa GP; Sousa-Pinto B; Ferreira E; Araújo O; Barilaro G; Bettencourt P; Cervera R; Espinosa G Arthritis Res Ther; 2022 Jan; 24(1):9. PubMed ID: 34980238 [TBL] [Abstract][Full Text] [Related]
4. The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity. Xie H; Sheng L; Zhou H; Yan J Br J Haematol; 2014 Jan; 164(2):165-76. PubMed ID: 24180619 [TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid syndrome, "the best prophet of the future". Amengual O; Atsumi T Mod Rheumatol; 2018 May; 28(3):409-416. PubMed ID: 29385876 [TBL] [Abstract][Full Text] [Related]
6. Seronegative antiphospholipid syndrome: refining the value of "non-criteria" antibodies for diagnosis and clinical management. Pignatelli P; Ettorre E; Menichelli D; Pani A; Violi F; Pastori D Haematologica; 2020 Mar; 105(3):562-572. PubMed ID: 32001534 [TBL] [Abstract][Full Text] [Related]
7. Carbamylation of β2-glycoprotein I generates new autoantigens for antiphospholipid syndrome: a new tool for diagnosis of 'seronegative' patients. Capozzi A; Truglia S; Buttari B; Recalchi S; Riitano G; Manganelli V; Mancuso S; Alessandri C; Longo A; Mattei V; Profumo E; Garofalo T; Misasi R; Conti F; Sorice M Rheumatology (Oxford); 2022 Oct; 61(10):4187-4197. PubMed ID: 35108369 [TBL] [Abstract][Full Text] [Related]
8. Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients. Li C; Zuo Y; Zhang S; Makris UE; Karp DR; Li Z Chin Med J (Engl); 2022 Mar; 135(6):658-664. PubMed ID: 35143425 [TBL] [Abstract][Full Text] [Related]
9. Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called 'seronegative APS'). Rodriguez-Garcia JL; Bertolaccini ML; Cuadrado MJ; Sanna G; Ateka-Barrutia O; Khamashta MA Ann Rheum Dis; 2012 Feb; 71(2):242-4. PubMed ID: 21953349 [TBL] [Abstract][Full Text] [Related]
10. The antiphospholipid syndrome: still an enigma. Chaturvedi S; McCrae KR Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701 [TBL] [Abstract][Full Text] [Related]
11. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome. Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498 [TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of thrombosis and potential targeted therapies in antiphospholipid syndrome. Amengual O; Atsumi T; Koike T Curr Vasc Pharmacol; 2011 Sep; 9(5):606-18. PubMed ID: 21692741 [TBL] [Abstract][Full Text] [Related]
14. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome. Forastiero R; Martinuzzo M Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486 [TBL] [Abstract][Full Text] [Related]
15. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome. Robbins DL; Leung S; Miller-Blair DJ; Ziboh V J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202 [TBL] [Abstract][Full Text] [Related]
16. Complement in the Pathophysiology of the Antiphospholipid Syndrome. Chaturvedi S; Brodsky RA; McCrae KR Front Immunol; 2019; 10():449. PubMed ID: 30923524 [TBL] [Abstract][Full Text] [Related]